Radio Advisory

In this episode, Abby Burns welcomes back Megan Zweig, CEO of Rock Health Advisory, to answer audience questions submitted during Advisory Board's Research Summit in Carlsbad, California.

Together, they explore how health systems are engaging with the explosion in consumer-generated data, the role of medtech and pharma in AI-enabled innovation, and why AI enablement may be able to unlock personalized care for a wider range of patients.

We’re here to help:

Episode | 304: Boom, bust, or bubble? Rock Health weighs in on digital health funding in 2026

Playlist | Radio Advisory Tech and AI playlist

Playlist | Radio Advisory Provider Strategy and Financial Outlook playlist

Research | AI in healthcare: Evaluating promising use cases

Research | Truly personalized care is possible. Here's how to make it a reality.

Rock Health
H1 2026 funding and market overview: Durable roots, shifting routes | Rock Health

Want to see a live recording of Radio Advisory? Register for an Advisory Board summit and get the insights your organization needs to navigate uncertainty and build lasting resilience.

Advisory Board members: Action requested! Help shape Advisory Board’s next research agenda by taking our quick survey — share your priorities and challenges to ensure our research reflects what matters most to healthcare leaders like you.

Nearly 70% of adults ages 65 and over skipped the latest COVID vaccine. Learn how health systems can treat vaccine uncertainty as a routine care gap — not patient resistance — by reading Advisory Board’s expert insight.

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Oncology is simultaneously one of healthcare's greatest success stories and one of its biggest financial challenges. Cancer care continues to benefit from breakthroughs in precision medicine and early detection, even as oncology spending is projected to approach $200 billion by 2029. At the same time, cancer programs are facing rising patient volumes, growing demand for advanced therapies, and mounting pressure to improve access and affordability.

In this episode, hosts Abby Burns and Chloe Bakst welcome oncology expert Gaby Marmolejos to break down the trends shaping cancer care in 2026 and beyond. Together, they explore improvements in community-based access to advanced therapies, the promise of multi-cancer early detection testing, and the reimbursement challenges threatening program sustainability.

We’re here to help:

Playbook | Cell and gene therapy programs: How to launch, optimize, and deliver CGTs sustainably

Roundtable referenced | Advisory Board Oncology Roundtable: Trends and tech you can’t ignore

Webinar | The top 4 trends in oncology today

Report | Prioritizing equity in cancer treatment: Emerging ideas

Episode | 270: Service line snapshot: What every health leader needs to know

Episode | Ep. 209: Predicting what oncology will look like in 2030

Help shape Advisory Board’s next research agenda by taking our quick survey — share your priorities and challenges to ensure our research reflects what matters most to healthcare leaders like you.

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Value-based care is entering its accountability era. Participation in value-based arrangements continues to grow, even as financial pressures weigh down on both providers and payers. But CMMI is setting a clear tone about what it expects from stakeholders moving forward: results.

Host Abby Burns sits down with Advisory Board experts Clare Wirth, Payton Grimes, and Rhea Jain to explore what’s changed — and what hasn’t — in value-based care. From Medicare Advantage turbulence to the push for specialist engagement and greater downside risk, the group breaks down what leaders need to know about how the value-based care landscape is evolving.

We’re here to help:

Expert Insight | VBC in 2026: What was, what’s now, and what’s next

Ready-to-Use Resource | Your guide to CMMI’s 25+ innovation models

Case Study | Astera and Vantris are disrupting oncology with condition-based bundles

Case Study | HOPCo’s total cost of care approach to VBC in MSK care

Case Study referenced | How Optum Health defines and upholds value in specialty care

Episode | Ep. 243: What’s now and what’s next in value-based care

Playlist | Value-Based Care

Roundtable | HOME - Advisory Board VBC Roundtable: How to deliver the next era of VBC

Help shape Advisory Board’s next research agenda by taking our quick survey — share your priorities and challenges to ensure our research reflects what matters most to healthcare leaders like you.

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

After years of uncertainty, many healthcare executives say they’ve experienced more change in the past five years than in their entire careers. Policy shifts, evolving patient expectations, and rapid advances in AI are all colliding at once — forcing leaders to rethink how they operate and where they invest.

But here’s the surprising part: the overwhelming sentiment isn’t panic. It’s clarity.

In this episode, host Rachel (Rae) Woods sits down with Advisory Board researchers Morghen Philippi and Marisa Nives to share what they’re hearing from months of research conversations with leaders across the ecosystem. Together, they offer a grounded look at how peers, partners, and competitors are thinking right now — where leaders are aligned, where they’re making different bets, and what they’re prioritizing next.

We’re here to help:

Episode | Ep. 303: The hard truths behind the fight for commercial volumes

Episode | Ep. 232: The rise of ICHRAs: Why some employers are turning to the individual market

Playlist | Strategy and Financial Outlook playlist

Report | 12 things CEOs need to know in 2026

Report | Survey insights: The 5 trends redefining health system strategy in 2026

Tool | Check out Advisory Board’s Market Scenario Planner and other Advisory Board analytics and data tools to inform your strategy for growth, cost control and more.

Ready-to-Use Slides | Market outlook for individual and small group health insurance

Webinar | How to embrace a proactive (not reactive) approach to change

Q&A with a clinical pharmacist: Reimagining diabetes care

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Digital health funding is heating up—but where are the dollars going? And what does it mean for health systems’ digital health strategies?

In this live episode, recorded at Advisory Board’s Research Summit, host Abby Burns sits down with Megan Zweig, President and CEO of Rock Health Advisory, for an update on what’s going on in the world of digital health funding. Together, they unpack what investment activity looks like and explore questions around what constitutes an investable thesis in 2026, how health systems are—or could be—engaging in the startup ecosystem, and what it takes to be a good incubation partner.

We’re here to help:

Episode | 298: Battle of the bots? Separating AI hype from value in revenue cycle

Episode | 254: Stop searching for the “perfect” AI product and do this instead

Playlist | Radio Advisory Tech and AI playlist

Playlist | Radio Advisory Provider Strategy and Financial Outlook playlist

Research | AI in healthcare: Evaluating promising use cases

Rock Health

Want to see a live recording of Radio Advisory? Register for an Advisory Board summit and get the insights your organization needs to navigate uncertainty and build lasting resilience.

The role of pharmacists in cardiometabolic care

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.